首页 > 最新文献

Vascular Medicine最新文献

英文 中文
Carotid artery ultrasound grayscale median and incident dementia: The Multi-Ethnic Study of Atherosclerosis (MESA). 颈动脉超声灰度中值与痴呆:动脉粥样硬化(MESA)的多民族研究。
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2026-01-07 DOI: 10.1177/1358863X251396507
Matthew C Tattersall, Carol C Mitchell, Ronald E Gangnon, Claudia E Korcarz, Kristin M Hansen, Adam D Gepner, Stephen R Rapp, Sterling C Johnson, James H Stein

Introduction: Vascular contributions to cognitive impairment and dementia are potentially modifiable. Early detection of reversible arterial injury may improve risk stratification and provide treatment monitoring. We hypothesized that carotid ultrasound grayscale median (GSM), a novel imaging biomarker of early arterial injury, would predict incident all-cause dementia in the Multi-Ethnic Study of Atherosclerosis (MESA).

Methods: The MESA enrolled adults free of atherosclerotic cardiovascular disease. Common carotid GSM was measured at baseline. Incident all-cause dementia events were identified by hospital and death records. Cox proportional hazards models with natural cubic splines investigated the association of baseline GSM and all-cause dementia.

Results: The 1788 participants were a mean (SD) 63.1 (10.3) years old and 53% were women. Over a median 13.7 years, 157 all-cause dementia events occurred. In fully adjusted models, with additional adjustment for carotid intima-media thickness, lower (worse) GSM independently predicted incident all-cause dementia (hazard ratio, 1st to 3rd tertile, 1.45 [95% CI, 1.11-1.90], p = 0.021).

Conclusions: Lower GSM independently predicts all-cause dementia, beyond traditional arterial injury measures, suggesting it may serve as an early marker of dementia risk.

血管对认知障碍和痴呆的影响是可以改变的。早期发现可逆性动脉损伤可以改善风险分层和提供治疗监测。在多种族动脉粥样硬化研究(MESA)中,我们假设颈动脉超声灰度中位数(GSM)是一种早期动脉损伤的新型成像生物标志物,可以预测全因痴呆的发生。方法:MESA纳入无动脉粥样硬化性心血管疾病的成年人。在基线时测量颈总动脉GSM。通过医院和死亡记录确定事件性全因痴呆事件。Cox自然三次样条比例风险模型研究了基线GSM与全因痴呆的关系。结果:1788名参与者平均(SD) 63.1(10.3)岁,其中53%为女性。在平均13.7年的时间里,发生了157例全因痴呆事件。在完全调整的模型中,对颈动脉内膜-中膜厚度进行额外调整,较低(较差)的GSM独立预测全因痴呆的发生(风险比,1至3个分位数,1.45 [95% CI, 1.11-1.90], p = 0.021)。结论:较低的GSM独立预测全因痴呆,超越传统的动脉损伤指标,表明它可能作为痴呆风险的早期标志。
{"title":"Carotid artery ultrasound grayscale median and incident dementia: The Multi-Ethnic Study of Atherosclerosis (MESA).","authors":"Matthew C Tattersall, Carol C Mitchell, Ronald E Gangnon, Claudia E Korcarz, Kristin M Hansen, Adam D Gepner, Stephen R Rapp, Sterling C Johnson, James H Stein","doi":"10.1177/1358863X251396507","DOIUrl":"10.1177/1358863X251396507","url":null,"abstract":"<p><strong>Introduction: </strong>Vascular contributions to cognitive impairment and dementia are potentially modifiable. Early detection of reversible arterial injury may improve risk stratification and provide treatment monitoring. We hypothesized that carotid ultrasound grayscale median (GSM), a novel imaging biomarker of early arterial injury, would predict incident all-cause dementia in the Multi-Ethnic Study of Atherosclerosis (MESA).</p><p><strong>Methods: </strong>The MESA enrolled adults free of atherosclerotic cardiovascular disease. Common carotid GSM was measured at baseline. Incident all-cause dementia events were identified by hospital and death records. Cox proportional hazards models with natural cubic splines investigated the association of baseline GSM and all-cause dementia.</p><p><strong>Results: </strong>The 1788 participants were a mean (SD) 63.1 (10.3) years old and 53% were women. Over a median 13.7 years, 157 all-cause dementia events occurred. In fully adjusted models, with additional adjustment for carotid intima-media thickness, lower (worse) GSM independently predicted incident all-cause dementia (hazard ratio, 1st to 3rd tertile, 1.45 [95% CI, 1.11-1.90], <i>p</i> = 0.021).</p><p><strong>Conclusions: </strong>Lower GSM independently predicts all-cause dementia, beyond traditional arterial injury measures, suggesting it may serve as an early marker of dementia risk.</p>","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"28-34"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical features and prognosis in patients with chronic limb-threatening ischemia receiving welfare in Japan. 日本接受福利的慢性肢体缺血患者的临床特征和预后。
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2026-01-20 DOI: 10.1177/1358863X251404438
Yosuke Hata, Osamu Iida, Mitsuyoshi Takahara, Norihiko Ohura, Akio Kodama, Yoshimitsu Soga, Terutoshi Yamaoka, Nobuyoshi Azuma

Background: In patients with chronic limb-threatening ischemia (CLTI), a subset of patients are beneficiaries of welfare assistance. We sought to investigate the clinical features and prognosis of patients with CLTI receiving welfare compared to those not receiving welfare in the Japanese population.

Methods: This is a subanalysis of the multicenter, prospective Wound-directed Angiosome RevasculaRIzation apprOach to patients with cRitical limb iSchemia (WARRIORS) registry. We evaluated 440 patients with CLTI accompanied by tissue loss undergoing infrapopliteal revascularization. The outcome measures included a 24-month wound-healing rate, and overall survival and follow-up continuity. We compared the outcomes between the welfare and nonwelfare groups (n = 48 and 392, respectively) using the Kaplan-Meier method and log-rank tests.

Results: Frequencies of nonambulatory status, diabetes mellitus, hemodialysis, and wound severity stratified by Wound, Ischemia, and foot Infection classification showed no significant inter-group differences. The number of patients treated with bypass surgery was lower in the welfare group than in the nonwelfare group. The 24-month wound healing and follow-up continuity rates were significantly lower in the welfare group compared to the nonwelfare group (37.3% vs 59.6%, p = 0.005 and 47.9% vs 58.0%, p = 0.048, respectively). In contrast, the 24-month overall survival rate did not differ significantly between the groups (63.1% vs 71.7%, p = 0.27).

Conclusions: Patients receiving welfare had significantly worse wound-healing rates and a higher loss to follow up even within the framework of the Japanese universal health insurance system.

背景:在慢性肢体威胁缺血(CLTI)患者中,一部分患者是福利援助的受益者。我们试图调查日本人群中接受福利治疗的CLTI患者与未接受福利治疗的患者的临床特征和预后。方法:这是一项多中心、前瞻性伤口导向血管小体血运重建术治疗重度肢体缺血(WARRIORS)登记患者的亚分析。我们评估了440例伴有组织丢失的CLTI患者行腘下血管重建术。结果测量包括24个月的伤口愈合率,总生存率和随访连续性。我们使用Kaplan-Meier方法和log-rank检验比较了福利组和非福利组(n = 48和392)的结果。结果:非活动状态、糖尿病、血液透析和伤口严重程度的频率按伤口、缺血和足部感染分类分层,组间差异无统计学意义。接受搭桥手术的患者数量在福利组低于非福利组。与非福利组相比,福利组的24个月伤口愈合率和随访连续性率显著降低(分别为37.3%对59.6%,p = 0.005和47.9%对58.0%,p = 0.048)。相比之下,两组间24个月的总生存率无显著差异(63.1% vs 71.7%, p = 0.27)。结论:即使在日本全民健康保险制度框架内,接受福利的患者伤口愈合率明显较差,随访损失较高。
{"title":"Clinical features and prognosis in patients with chronic limb-threatening ischemia receiving welfare in Japan.","authors":"Yosuke Hata, Osamu Iida, Mitsuyoshi Takahara, Norihiko Ohura, Akio Kodama, Yoshimitsu Soga, Terutoshi Yamaoka, Nobuyoshi Azuma","doi":"10.1177/1358863X251404438","DOIUrl":"10.1177/1358863X251404438","url":null,"abstract":"<p><strong>Background: </strong>In patients with chronic limb-threatening ischemia (CLTI), a subset of patients are beneficiaries of welfare assistance. We sought to investigate the clinical features and prognosis of patients with CLTI receiving welfare compared to those not receiving welfare in the Japanese population.</p><p><strong>Methods: </strong>This is a subanalysis of the multicenter, prospective Wound-directed Angiosome RevasculaRIzation apprOach to patients with cRitical limb iSchemia (WARRIORS) registry. We evaluated 440 patients with CLTI accompanied by tissue loss undergoing infrapopliteal revascularization. The outcome measures included a 24-month wound-healing rate, and overall survival and follow-up continuity. We compared the outcomes between the welfare and nonwelfare groups (<i>n</i> = 48 and 392, respectively) using the Kaplan-Meier method and log-rank tests.</p><p><strong>Results: </strong>Frequencies of nonambulatory status, diabetes mellitus, hemodialysis, and wound severity stratified by Wound, Ischemia, and foot Infection classification showed no significant inter-group differences. The number of patients treated with bypass surgery was lower in the welfare group than in the nonwelfare group. The 24-month wound healing and follow-up continuity rates were significantly lower in the welfare group compared to the nonwelfare group (37.3% vs 59.6%, <i>p</i> = 0.005 and 47.9% vs 58.0%, <i>p</i> = 0.048, respectively). In contrast, the 24-month overall survival rate did not differ significantly between the groups (63.1% vs 71.7%, <i>p</i> = 0.27).</p><p><strong>Conclusions: </strong>Patients receiving welfare had significantly worse wound-healing rates and a higher loss to follow up even within the framework of the Japanese universal health insurance system.</p>","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"63-69"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuts and bolts of venous and lymphatic care: Practical strategies from the Society for Vascular Medicine's 2025 Vascular Scientific Sessions. 静脉和淋巴护理的具体细节:来自血管医学学会2025年血管科学会议的实用策略。
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2026-01-21 DOI: 10.1177/1358863X251411883
Eri Fukaya, Raghu Kolluri
{"title":"Nuts and bolts of venous and lymphatic care: Practical strategies from the Society for Vascular Medicine's 2025 Vascular Scientific Sessions.","authors":"Eri Fukaya, Raghu Kolluri","doi":"10.1177/1358863X251411883","DOIUrl":"10.1177/1358863X251411883","url":null,"abstract":"","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"134-136"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146019227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of neuromuscular electrical stimulation on symptoms of chronic venous disease of the lower limbs: A systematic review. 神经肌肉电刺激对下肢慢性静脉疾病症状的影响:系统综述。
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-10-07 DOI: 10.1177/1358863X251361486
Mariana Santos, Raquel Pires, Joana Ferreira, Marina Dias-Neto

Introduction: Chronic venous disease (CVD) is highly prevalent, imposing a significant burden on patients. Treatment options include surgical and nonsurgical modalities. Neuromuscular electrical stimulation (NMES) is an alternative that artificially activates the calf muscle pump, improving blood flow parameters. This systematic review evaluates its effectiveness in relieving CVD symptoms.

Methods: PubMed, Web of Science, and Scopus were sought for experimental and observational studies published between 2000 and March 2025. Included studies assessed NMES for CVD symptoms. Exclusion criteria were electrode application directly to or around ulcers and sample sizes under 10 patients. The primary objective included peripheral edema, quality of life, venous leg ulcer healing, and leg pain. Adverse effects were the secondary outcome. Risk of bias was evaluated using appropriate tools.

Results: Out of 269 records gathered, eight were included (three randomized controlled trials, one nonrandomized controlled trial, and four case series), totaling 311 patients, 214 of whom used NMES. The mean age was 56.7 years (95% CI: 48.0-65.4 years) and 49.9% (95% CI 40.5-59.2%) were women. Devices used were Geko and Veinoplus (three studies each) and Revitive IX (two studies). Six studies evaluated edema, with a decrease in NMES groups in four. Quality of life was evaluated in five studies; pain and ulcer healing were appraised in three each, all showing improvement. Reported adverse effects included mild skin irritation and rash.

Conclusion: NMES shows promising results across all outcomes studied. However, studies may suffer from publication or selection bias, imperfect designs, and other individual factors. (PROSPERO registration No.: CRD42023401762).

慢性静脉疾病(CVD)非常普遍,给患者带来了巨大的负担。治疗方案包括手术和非手术方式。神经肌肉电刺激(NMES)是一种人工激活小腿肌肉泵,改善血液流动参数的替代方法。本系统综述评价其缓解心血管疾病症状的有效性。方法:检索2000年至2025年3月期间发表的实验和观察性研究,检索PubMed、Web of Science和Scopus。纳入的研究评估了NMES对CVD症状的影响。排除标准是电极直接应用于溃疡或溃疡周围,样本量小于10例。主要目的包括外周水肿、生活质量、腿部静脉溃疡愈合和腿部疼痛。不良反应是次要结局。使用适当的工具评估偏倚风险。结果:在收集到的269份记录中,纳入8份(3份随机对照试验,1份非随机对照试验,4份病例系列),共计311例患者,其中214例患者使用NMES。平均年龄为56.7岁(95% CI: 48.0 ~ 65.4岁),女性为49.9% (95% CI: 40.5 ~ 59.2%)。使用的器械是Geko和Veinoplus(各3项研究)和Revitive IX(2项研究)。6项研究评估水肿,其中4项NMES组水肿减少。在五项研究中评估了生活质量;疼痛和溃疡愈合各有3项,均有改善。报告的不良反应包括轻度皮肤刺激和皮疹。结论:NMES在所有研究结果中都显示出令人鼓舞的结果。然而,研究可能受到发表或选择偏差、设计不完美和其他个体因素的影响。普洛斯彼罗注册号:: CRD42023401762)。
{"title":"Effects of neuromuscular electrical stimulation on symptoms of chronic venous disease of the lower limbs: A systematic review.","authors":"Mariana Santos, Raquel Pires, Joana Ferreira, Marina Dias-Neto","doi":"10.1177/1358863X251361486","DOIUrl":"10.1177/1358863X251361486","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic venous disease (CVD) is highly prevalent, imposing a significant burden on patients. Treatment options include surgical and nonsurgical modalities. Neuromuscular electrical stimulation (NMES) is an alternative that artificially activates the calf muscle pump, improving blood flow parameters. This systematic review evaluates its effectiveness in relieving CVD symptoms.</p><p><strong>Methods: </strong>PubMed, Web of Science, and Scopus were sought for experimental and observational studies published between 2000 and March 2025. Included studies assessed NMES for CVD symptoms. Exclusion criteria were electrode application directly to or around ulcers and sample sizes under 10 patients. The primary objective included peripheral edema, quality of life, venous leg ulcer healing, and leg pain. Adverse effects were the secondary outcome. Risk of bias was evaluated using appropriate tools.</p><p><strong>Results: </strong>Out of 269 records gathered, eight were included (three randomized controlled trials, one nonrandomized controlled trial, and four case series), totaling 311 patients, 214 of whom used NMES. The mean age was 56.7 years (95% CI: 48.0-65.4 years) and 49.9% (95% CI 40.5-59.2%) were women. Devices used were Geko and Veinoplus (three studies each) and Revitive IX (two studies). Six studies evaluated edema, with a decrease in NMES groups in four. Quality of life was evaluated in five studies; pain and ulcer healing were appraised in three each, all showing improvement. Reported adverse effects included mild skin irritation and rash.</p><p><strong>Conclusion: </strong>NMES shows promising results across all outcomes studied. However, studies may suffer from publication or selection bias, imperfect designs, and other individual factors. <b>(PROSPERO registration No.</b>: <b>CRD42023401762)</b>.</p>","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"114-123"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145239798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum.
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-10-28 DOI: 10.1177/1358863X251393861
{"title":"Corrigendum.","authors":"","doi":"10.1177/1358863X251393861","DOIUrl":"10.1177/1358863X251393861","url":null,"abstract":"","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"NP1"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the Masters: Pioneering pulse-The story of vascular medicine in the Philippines. 来自大师:先驱脉搏-菲律宾血管医学的故事。
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2026-01-07 DOI: 10.1177/1358863X251396541
Maria Teresa B Abola
{"title":"From the Masters: Pioneering pulse-The story of vascular medicine in the Philippines.","authors":"Maria Teresa B Abola","doi":"10.1177/1358863X251396541","DOIUrl":"10.1177/1358863X251396541","url":null,"abstract":"","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"3-9"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145913160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Arterial stiffness is related to a higher risk of cardiovascular events in patients with pseudoxanthoma elasticum (PXE). 在弹性假性黄瘤(PXE)患者中,动脉僵硬与心血管事件的高风险相关。
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2026-01-21 DOI: 10.1177/1358863X251394284
Melanie Haverkamp, Pim A de Jong, Frank Lj Visseren, Wilko Spiering

Background: Pseudoxanthoma elasticum (PXE) is a rare disease caused by pathogenic ABCC6 variants, leading to arterial calcifications and increased cardiovascular risk. Validated intermediate endpoints are needed to evaluate cardiovascular risk-reducing therapies in PXE. This prospective cohort study investigates the relationship between arterial stiffness and cardiovascular events in patients with PXE. Methods: This prospective cohort study obtained patients from the Dutch University Medical Center Utrecht Expertise Center for PXE. Arterial stiffness was measured with carotid-femoral pulse wave velocity (cfPWV) and the augmentation index (AIx). Cardiovascular endpoints were cardiovascular death, cerebrovascular and coronary events, and peripheral artery interventions. Cox proportional hazard models analyzed associations between arterial stiffness and cardiovascular events, adjusting for confounders. Results: Among 390 patients (mean age 51 ± 15 years, 60% women), 45 cardiovascular events occurred during a median follow up of 6.1 years (IQR 3.2; 9.2). A 1-m/s higher cfPWV was related to an increased risk of cardiovascular events (hazard ratio [HR]: 1.28; 95% CI 1.06-1.53). The effect of cfPWV depends on age (p-value = 0.03), with a lower cardiovascular risk HR at older age (HR age at 40 years: 1.51; 95% CI 1.11-1.97 to HR age at 60 years: 1.12; 95% CI 1.00-1.26). A 10% higher AIx at baseline was related to future cardiovascular events (HR 1.46; 95% CI 1.10-1.95). No significant interaction between the AIx and age was found. Conclusion: This prospective cohort study shows that arterial stiffness, measured by cfPWV and AIx, is independently associated with increased cardiovascular risk in PXE. Measures of arterial stiffness could be explored as intermediate endpoints in trials evaluating cardiovascular risk-reducing therapies in PXE.

背景:弹性假性黄瘤(PXE)是一种由致病性ABCC6变异引起的罕见疾病,可导致动脉钙化和心血管风险增加。需要经过验证的中间终点来评估PXE患者的心血管风险降低治疗。这项前瞻性队列研究调查了PXE患者动脉僵硬度与心血管事件之间的关系。方法:这项前瞻性队列研究获得了来自荷兰大学医学中心乌得勒支专家中心的PXE患者。用颈-股脉波速度(cfPWV)和增强指数(AIx)测量动脉僵硬度。心血管终点为心血管死亡、脑血管和冠状动脉事件以及外周动脉干预。Cox比例风险模型分析了动脉硬度和心血管事件之间的关系,调整了混杂因素。结果:390例患者(平均年龄51±15岁,60%为女性)中位随访6.1年(IQR 3.2; 9.2),发生45例心血管事件。cfPWV升高1 m/s与心血管事件风险增加相关(危险比[HR]: 1.28; 95% CI 1.06-1.53)。cfPWV的影响取决于年龄(p值= 0.03),年龄越大心血管风险HR越低(40岁时的HR: 1.51; 95% CI 1.11-1.97; 60岁时的HR: 1.12; 95% CI 1.00-1.26)。基线时AIx升高10%与未来心血管事件相关(HR 1.46; 95% CI 1.10-1.95)。在AIx和年龄之间没有发现明显的相互作用。结论:这项前瞻性队列研究表明,cfPWV和AIx测量的动脉硬度与PXE患者心血管风险增加独立相关。在评估PXE患者心血管风险降低治疗的试验中,动脉僵硬度的测量可以作为中间终点。
{"title":"Arterial stiffness is related to a higher risk of cardiovascular events in patients with pseudoxanthoma elasticum (PXE).","authors":"Melanie Haverkamp, Pim A de Jong, Frank Lj Visseren, Wilko Spiering","doi":"10.1177/1358863X251394284","DOIUrl":"10.1177/1358863X251394284","url":null,"abstract":"<p><p><b>Background:</b> Pseudoxanthoma elasticum (PXE) is a rare disease caused by pathogenic <i>ABCC6</i> variants, leading to arterial calcifications and increased cardiovascular risk. Validated intermediate endpoints are needed to evaluate cardiovascular risk-reducing therapies in PXE. This prospective cohort study investigates the relationship between arterial stiffness and cardiovascular events in patients with PXE. <b>Methods:</b> This prospective cohort study obtained patients from the Dutch University Medical Center Utrecht Expertise Center for PXE. Arterial stiffness was measured with carotid-femoral pulse wave velocity (cfPWV) and the augmentation index (AIx). Cardiovascular endpoints were cardiovascular death, cerebrovascular and coronary events, and peripheral artery interventions. Cox proportional hazard models analyzed associations between arterial stiffness and cardiovascular events, adjusting for confounders. <b>Results:</b> Among 390 patients (mean age 51 ± 15 years, 60% women), 45 cardiovascular events occurred during a median follow up of 6.1 years (IQR 3.2; 9.2). A 1-m/s higher cfPWV was related to an increased risk of cardiovascular events (hazard ratio [HR]: 1.28; 95% CI 1.06-1.53). The effect of cfPWV depends on age (<i>p</i>-value = 0.03), with a lower cardiovascular risk HR at older age (HR age at 40 years: 1.51; 95% CI 1.11-1.97 to HR age at 60 years: 1.12; 95% CI 1.00-1.26). A 10% higher AIx at baseline was related to future cardiovascular events (HR 1.46; 95% CI 1.10-1.95). No significant interaction between the AIx and age was found. <b>Conclusion:</b> This prospective cohort study shows that arterial stiffness, measured by cfPWV and AIx, is independently associated with increased cardiovascular risk in PXE. Measures of arterial stiffness could be explored as intermediate endpoints in trials evaluating cardiovascular risk-reducing therapies in PXE.</p>","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"19-27"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12901643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146019012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing guideline adherence and readability: Artificial intelligence with deep learning versus specialized physicians in peripheral artery disease management. 比较指南的依从性和可读性:人工智能与深度学习与外周动脉疾病管理的专业医生。
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-12-18 DOI: 10.1177/1358863X251386394
Alfredo Verastegui, Regina Castaneda, Oliver Antonio Gómez-Gutiérrez, Mauricio Gonzalez-Urquijo, Oscar de la Torre, Diego Herrera Vegas, August Ysa, Manuel García-Toca, Mario Alejandro Fabiani

Background: Peripheral artery disease (PAD) is a global health challenge. Advances in artificial intelligence (AI), such as large language models (LLMs) and chain-of-thought (CoT) reasoning, offer novel approaches for clinical recommendations. This study compared the readability and guideline adherence of responses from physicians and AI for a standardized PAD case.

Methods: This cross-sectional study gathered responses from 30 specialized physicians (11 cardiologists, 19 vascular surgeons) across seven Latin American countries and 13 LLM systems (10 standard, three CoT). Both groups addressed diagnosis, treatment, risks, and prognosis; LLMs responded as vascular specialists. Responses were blindly evaluated with five validated Spanish readability indices and compared to the 2024 ACC/AHA multisocietal PAD guideline. Three experts scored guideline adherence; nonparametric tests were applied.

Results: Guideline adherence did not differ significantly between physicians (median 5.8 [3.4-7.6]) and LLMs (7.3 [4.7-9.7], p = 0.169), though CoT-LLMs achieved the highest scores (9.7 [8.5-11.0]). LLMs more often recommended supervised exercise (84.6% vs 30.0%, p = 0.002) and revascularization for quality of life (69.2% vs 20.0%, p = 0.004), whereas physicians favored cilostazol (60.0% vs 30.8%, p = 0.104). LLM responses had lower Readability μ values (46.9 vs 51.4, p = 0.012). Inter-rater reliability was highest for CoT-LLMs (intraclass correlation coefficient [ICC] = 0.98) versus physicians (ICC = 0.76).

Conclusion: LLM showed comparable guideline adherence to physicians although CoT models achieved the highest scores. The difference in physician and AI treatment preferences suggest the potential of AI as adjunct clinical tools and warrants further study.

背景:外周动脉疾病(PAD)是一个全球性的健康挑战。人工智能(AI)的进步,如大型语言模型(LLMs)和思维链(CoT)推理,为临床推荐提供了新的方法。本研究比较了医生和人工智能对一个标准化PAD病例反应的可读性和指南依从性。方法:这项横断面研究收集了来自7个拉丁美洲国家和13个LLM系统(10个标准,3个CoT)的30名专科医生(11名心脏病专家,19名血管外科医生)的反馈。两组都讨论了诊断、治疗、风险和预后;法学硕士的反应是血管专家。采用五种经过验证的西班牙语可读性指数进行盲评价,并与2024 ACC/AHA多社会PAD指南进行比较。3位专家对指南依从性进行评分;采用非参数检验。结果:医生(中位数5.8[3.4-7.6])和LLMs(中位数7.3 [4.7-9.7],p = 0.169)之间的指南依从性无显著差异,尽管CoT-LLMs得分最高(9.7[8.5-11.0])。llm更倾向于推荐有监督的运动(84.6% vs 30.0%, p = 0.002)和血运重建术(69.2% vs 20.0%, p = 0.004),而医生更倾向于西洛他唑(60.0% vs 30.8%, p = 0.104)。LLM反应的Readability μ值较低(46.9 vs 51.4, p = 0.012)。量表间信度最高的是CoT-LLMs(类内相关系数[ICC] = 0.98)和内科医生(ICC = 0.76)。结论:尽管CoT模型获得了最高的分数,但LLM与医生的指南依从性相当。医生和人工智能治疗偏好的差异表明,人工智能作为辅助临床工具的潜力值得进一步研究。
{"title":"Comparing guideline adherence and readability: Artificial intelligence with deep learning versus specialized physicians in peripheral artery disease management.","authors":"Alfredo Verastegui, Regina Castaneda, Oliver Antonio Gómez-Gutiérrez, Mauricio Gonzalez-Urquijo, Oscar de la Torre, Diego Herrera Vegas, August Ysa, Manuel García-Toca, Mario Alejandro Fabiani","doi":"10.1177/1358863X251386394","DOIUrl":"10.1177/1358863X251386394","url":null,"abstract":"<p><strong>Background: </strong>Peripheral artery disease (PAD) is a global health challenge. Advances in artificial intelligence (AI), such as large language models (LLMs) and chain-of-thought (CoT) reasoning, offer novel approaches for clinical recommendations. This study compared the readability and guideline adherence of responses from physicians and AI for a standardized PAD case.</p><p><strong>Methods: </strong>This cross-sectional study gathered responses from 30 specialized physicians (11 cardiologists, 19 vascular surgeons) across seven Latin American countries and 13 LLM systems (10 standard, three CoT). Both groups addressed diagnosis, treatment, risks, and prognosis; LLMs responded as vascular specialists. Responses were blindly evaluated with five validated Spanish readability indices and compared to the 2024 ACC/AHA multisocietal PAD guideline. Three experts scored guideline adherence; nonparametric tests were applied.</p><p><strong>Results: </strong>Guideline adherence did not differ significantly between physicians (median 5.8 [3.4-7.6]) and LLMs (7.3 [4.7-9.7], <i>p</i> = 0.169), though CoT-LLMs achieved the highest scores (9.7 [8.5-11.0]). LLMs more often recommended supervised exercise (84.6% vs 30.0%, <i>p</i> = 0.002) and revascularization for quality of life (69.2% vs 20.0%, <i>p</i> = 0.004), whereas physicians favored cilostazol (60.0% vs 30.8%, <i>p</i> = 0.104). LLM responses had lower Readability μ values (46.9 vs 51.4, <i>p</i> = 0.012). Inter-rater reliability was highest for CoT-LLMs (intraclass correlation coefficient [ICC] = 0.98) versus physicians (ICC = 0.76).</p><p><strong>Conclusion: </strong>LLM showed comparable guideline adherence to physicians although CoT models achieved the highest scores. The difference in physician and AI treatment preferences suggest the potential of AI as adjunct clinical tools and warrants further study.</p>","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"70-78"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145775905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Images in Vascular Medicine: Middle mesenteric artery. 血管医学图像:肠系膜中动脉。
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2025-12-15 DOI: 10.1177/1358863X251389874
Caroline H Kim, Klaus D Hagspiel
{"title":"Images in Vascular Medicine: Middle mesenteric artery.","authors":"Caroline H Kim, Klaus D Hagspiel","doi":"10.1177/1358863X251389874","DOIUrl":"10.1177/1358863X251389874","url":null,"abstract":"","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"124-125"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145757737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular Disease Patient Information Page: Schamberg disease (progressive pigmentary dermatosis). 血管医学患者信息页面:Schamberg病(进行性色素性皮肤病)。
IF 3.3 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE Pub Date : 2026-02-01 Epub Date: 2026-01-21 DOI: 10.1177/1358863X251407653
Sivan Naveh, Alexandra L Solomon, R Kevin Rogers, Margaret Boyle
{"title":"Vascular Disease Patient Information Page: Schamberg disease (progressive pigmentary dermatosis).","authors":"Sivan Naveh, Alexandra L Solomon, R Kevin Rogers, Margaret Boyle","doi":"10.1177/1358863X251407653","DOIUrl":"10.1177/1358863X251407653","url":null,"abstract":"","PeriodicalId":23604,"journal":{"name":"Vascular Medicine","volume":" ","pages":"131-133"},"PeriodicalIF":3.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146019261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1